Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Anxiety in Autistic Youth
NCT07439042Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2026
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buspirone in anxiety disorder, sponsored by Massachusetts General Hospital. Started Sep 2026; status: recruiting.
02
Drugs
buspirone
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07439042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439042.